Differences in Prevalence and Severity of Coronary Artery Disease by Three Metabolic Syndrome Definitions

Canadian Journal of Cardiology

Volumn 28, Issue 2, 2012, Pages 208-214

  Chang, Jung Jung ^a,b,c   Chu, Chi Ming ^d   Wang, Po Chang ^a   Lin, Yu Sheng ^a   Pan, Kuo Li ^a   Jang, Shih Jung ^a   Chang, Shih Tai ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE;

EID: 84862827729     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.10.016     Document Type: Article

References (22)

1. Farias D.R., Pereira A.F., Rosa G. Metabolic syndrome in coronary artery and occlusive vascular disease: a systemic review [Portuguese]. Arq Bras Cardiol 2010, 94:150-178.
2. Kang G., Guo L., Guo Z., et al. Impact of blood pressure and other components of the metabolic syndrome on the development of cardiovascular disease. Circ J 2010, 74:456-461.
3. Sone H., Mizuno S., Fujii H., et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients?. Analysis from the Japan Diabetes Complications Study. Diabetes Care 2005, 28:1463-1471.
4. Anvari M.S., Boroumand M.A., Pourgholi L., et al. Potential link of microalbuminuria with metabolic syndrome in patients undergoing coronary angiography. Arch Med Res 2009, 40:399-405.
5. Kim J.Y., Mun H.S., Lee B.K., et al. Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease. Yonsei Med J 2010, 51:676-682.
6. Tong P.C., Kong A.P., So W.Y., et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007, 30:1206-1211.
7. Ryan T.J., Bauman W.B., Kennedy J.W., et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1993, 88:2987-3007.
8. Bakker A.J. Detection of microalbuminuria: receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 1999, 22:307-313.
9. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
10. Cameron A.J., Shaw J.E., Zimmet P.Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004, 33:351-375.
11. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689.
12. Padwal R.S., Sharma A.M. Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome. Can J Cardiol 2010, 26(suppl C):18C-20C.
13. Hunt K.J., Resendez R.G., Williams K., et al. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004, 110:1251-1257.
14. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716.
15. Luk A.O., Ma R.C., So W.Y., et al. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease. Diabet Med 2008, 25:1419-1425.
16. Milionis H.J., Kostapanos M.S., Liberopoulos E.N., et al. Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects. Int J Clin Pract 2007, 61:545-551.
17. Lorenzo C., Williams K., Hunt K.J., et al. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007, 30:8-13.
18. Noto D., Barbagallo C.M., Cefalu A.B., et al. The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population. Atherosclerosis 2008, 197:147-153.
19. Najarian R.M., Sullivan L.M., Kannel W.B., et al. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med 2006, 166:106-111.
20. Leiter L.A., Fitchett D.H., Gilbert R.E., et al. Identification and management of cardiometabolic risk in Canada: a position paper by the Cardiometabolic Risk Working Group (executive summary). Can J Cardiol 2011, 27:124-131.
21. Solymoss B.C., Bourassa M.G., Campeau L., et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004, 93:159-164.
22. Alberti K.G., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.